Snippet Search

Searching 12,245,596 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 2614 matching articles

Results per page:

... surface. Most protocols use single agents (  mitomycin 
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Cohen, Mark S.; Al-kasspooles, Mazin F.; Williamson, Stephen K.; Henry, David; Broward, Melinda; Roby, Katherine F.
C or oxaliplatin) provided IP. ...
... from colorectal and appendiceal cancer.  Mitomycin 
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Speeten, Kurt; Stuart, O. Anthony; Chang, David; Mahteme, Haile; Sugarbaker, Paul H.
C is a drug often used in this clinical ...
... 12-year follow-up experience with topical  mitomycin 
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience
Kurli, Madhavi; Finger, Paul T.
chemotherapy for diffuse and multifocal ...
... combinations of 5-fluorouracil +   mitomycin 
Pharmacotherapy of Anal Cancer
Pharmacotherapy of Anal Cancer
Rogers, Jane E.; Eng, Cathy
or 5-fluorouracil + cisplatin, along with ...
... administered as a combination therapy with  mitomycin 
Preclinical antitumor activity of a nanoparticulate SN38
Preclinical antitumor activity of a nanoparticulate SN38
Al-kasspooles, Mazin F.; Williamson, Stephen K.; Henry, David; Howell, Jahna; Niu, Fengui; Decedue, Charles J.; Roby, Katherine F.
C was more effective than the combination ...
... using the lysogenic induction agent  mitomycin 
Characterization of Lysogens in Bacterioplankton Assemblages of the Southern California Borderland
Characterization of Lysogens in Bacterioplankton Assemblages of the Southern California Borderland
Hewson, Ian; Fuhrman, Jed A.
C. ...
... contrast results using two chemoperfusates:  mitomycin 
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Blackham, Aaron U.; Shen, Perry; Stewart, John H.; Russell, Gregory B.; Levine, Edward A.
and cisplatin. ...
... approach using chemotherapeutic agent  mitomycin 
Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells
Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells
Kim, Seog-Young; Lee, Dae-Hee; Song, Xinxin; Bartlett, David L.; Kwon, Yong Tae; Lee, Yong J.
C, biologic agent tumor necrosis ...
... tissue culture wells then interrogated with  mitomycin 
Parallel determination of phenotypic cytotoxicity with a micropattern of mutant cell lines
Parallel determination of phenotypic cytotoxicity with a micropattern of mutant cell lines
Sincic, Ryan S.; Chang-Yen, David A.; Eddings, Mark; Barrows, Louis R.; Gale, Bruce K.
C, a chemotherapeutic agent. ...
... treated with hyperthermic intraperitoneal  mitomycin 
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Sugarbaker, Paul H.; Stuart, O. Anthony; Carmignani, C. Pablo
C chemotherapy after a complete ...
... technique, we administered hyperthermic  mitomycin 
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Tuttle, Todd M.; Zhang, Yan; Greeno, Edward; Knutsen, Amy
C into the peritoneal cavity for 90 min. ...
... from the stock bottle (106 units/mL). 12.  Mitomycin 
Methods for Culturing Mouse and Human Embryonic Stem Cells
Methods for Culturing Mouse and Human Embryonic Stem Cells
Lin, Sabrina; Talbot, Prue
C: reconstitute ...
... of intraoperative and postoperative topical  mitomycin 
Necrotizing scleritis as a complication of cosmetic eye whitening procedure
Necrotizing scleritis as a complication of cosmetic eye whitening procedure
Leung, Theresa G; Dunn, James P, Jr; Akpek, Esen K; Thorne, Jennifer E
C. ...
... When combined with the chemotherapeutic  mitomycin 
Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy
Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy
Sturm, Julia B; Hess, Michael; Weibel, Stephanie; Chen, Nanhai G; Yu, Yong A; Zhang, Qian; Donat, Ulrike; Reiss, Cora; Gambaryan, Stepan; Krohne, Georg; Stritzker, Jochen; Szalay, Aladar A
C, the anti-tumor effect of the oncolytic ...
... IV (DPPIV) − host rats are pretreated with  mitomycin 
Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat
Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat
Sanders, Jennifer A.
CMitomycin C to prevent adult hepatocyte ...
... To measure the clearance intraperitoneal  mitomycin 
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Lima Vazquez, Vinicius; Stuart, O. Anthony; Mohamed, Faheez; Sugarbaker, Paul H.
C and doxorubicin in patients having ...
... such as Tisseel fibrin sealant. Use of  Mitomycin 
Pterygium Surgery
Pterygium Surgery
Koplin, Richard S.; Wu, Elaine I.; Ritterband, David C.; Seedor, John A.
-C One of the main postoperative concern ...
... phacoemulsification and trabeculectomy with  mitomycin 
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial
Tanna, Angelo P.; Rademaker, Alfred W.; de Moraes, C. Gustavo; Godfrey, David G.; Sarkisian, Steven R., Jr.; Vold, Steven D.; Ritch, Robert
-C (MMC) vs. ...
... division using either a soluble inhibitor (  mitomycin 
Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications
Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications
King, William J.; Kouris, Nicholas A.; Choi, Siyoung; Ogle, Brenda M.; Murphy, William L.
C, Sigma, Saint Louis, MO, USA) or gamma ...
... each for thiotepa, doxorubicin, and  mitomycin 
Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor
Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor
Rosoff, James S.; Keane, Thomas E.
. ...
... Radiation therapy and 5-fluorouracil plus  mitomycin 
Chemotherapy of vulvar cancer: a review
Chemotherapy of vulvar cancer: a review
Deppe, Gunter; Mert, Ismail; Belotte, Jimmy; Winer, Ira S.
remains the standard therapy for anal ...
... than expected after CS-HIPEC with  mitomycin 
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C
Lange, Krystle N.; McKay, Danielle; Gentry, Brian G.; Franko, Jan
C (MMC), they investigated the ...
... concurrent with 5-fluorouracil and  mitomycin 
Invasive Anal Squamous-Cell Carcinoma in the HIV-Positive Patient: Outcome in the Era of Highly Active Antiretroviral Therapy
Invasive Anal Squamous-Cell Carcinoma in the HIV-Positive Patient: Outcome in the Era of Highly Active Antiretroviral Therapy
Wexler, Ann; Berson, Anthony M.; Goldstone, Stephen E.; Waltzman, Roger; Penzer, Jason; Maisonet, Olivier G.; McDermott, Bill; Rescigno, John
C in most patients. ...
... to review the main indications for use of  mitomycin 
A Review of Mitomycin Use in Ophthalmic Surgery: Clarification of Safety Standards for Patients and Hospital Personnel
A Review of Mitomycin Use in Ophthalmic Surgery: Clarification of Safety Standards for Patients and Hospital Personnel
Radke, Phillip M.; Bitrian, Elena; Kaufman, Stephen C.; Grajewski, Alana L.
in ophthalmology, the adverse effects after ...
... Feeder cells were treated with 10 μg/mL  mitomycin 
Optimization of culture conditions for porcine embryonic germ cells
Optimization of culture conditions for porcine embryonic germ cells
Dong, Xiao; Li, Yang; Wang, Hongjun
C for 2–3 h, re-seeded at a density of ...